{"organizations": [], "uuid": "dabfa09dccc1c6fb86a91abed719f7c140e87db0", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180216.html", "section_title": "Archive News &amp; Video for Friday, 16 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-stallergenes-greer-approval-in-jap/brief-stallergenes-greer-approval-in-japan-of-pediatric-use-for-actair-idUSFWN1Q603L", "country": "US", "domain_rank": 408, "title": "BRIEF-Stallergenes Greer ‍Approval In Japan Of Pediatric Use For Actair,​", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.924, "site_type": "news", "published": "2018-02-16T14:45:00.000+02:00", "replies_count": 0, "uuid": "dabfa09dccc1c6fb86a91abed719f7c140e87db0"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-stallergenes-greer-approval-in-jap/brief-stallergenes-greer-approval-in-japan-of-pediatric-use-for-actair-idUSFWN1Q603L", "ord_in_thread": 0, "title": "BRIEF-Stallergenes Greer ‍Approval In Japan Of Pediatric Use For Actair,​", "locations": [], "entities": {"persons": [{"name": "stallergenes greer", "sentiment": "negative"}], "locations": [{"name": "japan", "sentiment": "none"}, {"name": "japan", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "tner", "sentiment": "none"}, {"name": "shionogi & co. ltd.", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "gdynia newsroom", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 16 (Reuters) - STALLERGENES GREER PLC:\n* ‍APPROVAL IN JAPAN OF PEDIATRIC USE FOR ACTAIR®,​ * PARTNER IN JAPAN, SHIONOGI & CO. LTD., RECEIVED APPROVAL FOR EXTENSION OF INDICATION FOR ACTAIR​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-16T14:45:00.000+02:00", "crawled": "2018-02-17T14:40:29.000+02:00", "highlightTitle": ""}